Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Larimar Therapeutics (LRMR) Other Non Operating Income (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Other Non Operating Income for 7 consecutive years, with $57000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Other Non Operating Income rose 203.64% year-over-year to $57000.0, compared with a TTM value of $25000.0 through Dec 2019, up 110.55%, and an annual FY2019 reading of $25000.0, up 110.55% over the prior year.
  • Other Non Operating Income was $57000.0 for Q4 2019 at Larimar Therapeutics, up from -$33000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $100000.0 in Q1 2017 and bottomed at -$110000.0 in Q3 2015.
  • Average Other Non Operating Income over 5 years is -$9750.0, with a median of -$13500.0 recorded in 2017.
  • Peak annual rise in Other Non Operating Income hit 224.14% in 2016, while the deepest fall reached 1375.0% in 2016.
  • Year by year, Other Non Operating Income stood at $59000.0 in 2015, then tumbled by 264.41% to -$97000.0 in 2016, then soared by 125.77% to $25000.0 in 2017, then crashed by 320.0% to -$55000.0 in 2018, then soared by 203.64% to $57000.0 in 2019.
  • Business Quant data shows Other Non Operating Income for LRMR at $57000.0 in Q4 2019, -$33000.0 in Q3 2019, and -$22000.0 in Q2 2019.